Sirona Biochem
Biotechnology company developing diabetes therapeutics, as well as skin depigmenting and anti-aging agents.
Launch date
Employees
Market cap
CAD15.5m
Enterprise valuation
CAD18m (Public information from Sep 2024)
Share price
$0.0451 SRBCF
Vancouver British Columbia (HQ)
Financials
Estimates*
| CAD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | 1.3m | <1m | <1m | <1m | <1m | <1m |
| % growth | - | 23149 % | (89 %) | (22 %) | 154 % | 151 % | (95 %) |
| EBITDA | (4.1m) | (<1m) | (4.4m) | (4.1m) | (2.3m) | (3.5m) | (2.3m) |
| % EBITDA margin | (75269 %) | (72 %) | (3274 %) | (3897 %) | (850 %) | (524 %) | (6699 %) |
| Profit | (4.5m) | (1.3m) | (4.5m) | (4.1m) | (2.3m) | (3.6m) | (2.5m) |
| % profit margin | (81098 %) | (100 %) | (3352 %) | (3910 %) | (861 %) | (529 %) | (7312 %) |
| EV / revenue | 4921.8x | 15.0x | 709.1x | 532.4x | 174.2x | 48.8x | 662.8x |
| EV / EBITDA | -6.5x | -20.7x | -21.7x | -13.7x | -20.5x | -9.3x | -9.9x |
| R&D budget | <1m | <1m | 1.3m | 1.3m | 1.2m | 1.1m | 1.2m |
| R&D % of revenue | 18158 % | 74 % | 931 % | 1238 % | 431 % | 161 % | 3451 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
CAD80.0k | Grant | ||
| N/A | CAD1.4m | Post IPO Equity | |
| N/A | $665k | Convertible | |
* | N/A | $1.5m | Post IPO Convertible |
* | N/A | CAD133k | Private Placement non VC |
| Total Funding | CAD987k | ||
Related Content
Recent News about Sirona Biochem
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.